G. Aernout Somsen
CEO, Cardiologist and Founding Partner of Cardiology Centres of the Netherlands.
1993-1996 PhD study: “Cardiac Neuronal Dysfunction in Heart Failure Assessed by 123-Iodine Metaiodobenzylguanidine Scintigraphy”. (Financed by the Dutch Heart Foundation) Dept of Cardiology (head: prof. K.I. Lie) University of Amsterdam, the Netherlands.
1997-1998 Post-doc, Genetic basis of familial dilated cardiomyopathy. Harvard Medical School, Dept. of Genetics (heads: prof. CE Seidman and prof. J Seidman), Boston, USA. (Financed by the Dutch Royal Academy of Sciences).
Oct. 2002 Certified cardiologist in Switzerland, Chef de clinique, Cardiology Centre, University Hospital Geneva, Switzerland (head: prof. U. Sigwart)
Nov. 2003 Grants from: “Fondation Suisse de Cardiologie” and “Fonds de Service”. The effect of percuteneous transluminal alcohol septal ablation on contractile function, mechanical synchrony and neurohormonal activation in patients with hypertrophic obstructive cardiomyopathy. (principle investigator: GA Somsen)
2003 – 2013 Cardiologist and Program Director. Department of Cardiology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands.
2005 – 2006 Treasurer Working Group: MRI/MSCT en Nuclear Cardiology, Dutch Society of Cardiology (NVVC)
2006 – Founding partner of Cardiology Centres of the Netherlands; chain of private cardiology clinics.
2007- 2013 Member of Concilium Cardiologicum (Board of Program Directors)
2010 – 2017 Member of Working Group on Quality Assurance, NVVC
2011 – Fellow of The American College of Cardiology